Infectious Disease

• Slide sets for primary care physicians about hepatitis B and C, prepared May 2006. [BAC and FR, writers]

• Dropulic L. The impact of CMV infection on solid organ transplantation. Adv Stud Med. 2006;6(7):319-328. [FR, collaborating writer]

• Chin-Hong PV. Infections in patients with diabetes mellitus: importance of early recognition, treatment, and prevention. Adv Stud Med. 2006;6:71-81. [FR, collaborating writer]

• Infectious disease (teaching slides for geriatrics residents). American Geriatrics Society, http://teachingslides.americangeriatrics.org, January 2006. [BAC and FR, writers]

• Epidemiology and prevention of hepatitis. Coverage of the 2004 Annual Meeting of the American Association for the Study of Liver Diseases for ClinicalOptions.com. [FR, writer]

• Meeting reports, advisory board meetings about treatment of hepatitis C virus infection, 2003. [FR, collaborating writer]

• Anemia associated with the treatment of hepatitis C virus infection (slide set). National Anemia Action Council, 2003. [BAC and FR, writers]

• SARS: Here to stay? Review prepared March 2003. [BAC and FR, collaborating writers]

• Qualitative literature analysis about a protease inhibitor, prepared January 2003. [BAC and FR, researchers]

• Review of the long-term complications of nucleoside reverse transcriptase inhibitor therapy, prepared November 2002. [FR, collaborating writer]

Bylined news reports distributed on Reuters Health wire service [FR, writer]:

• Efficacy of chimp-vector HIV vaccine unaffected by human adenovirus antibodies, 2-21-2003.
• Polyclonal antibody against HIV passes muster in phase I trial, 2-10-2003.
• Active HPV-16 infection relatively uncommon in HIV-infected women in US, 1-27-2003.
• T cell-based TB test useful even in regions with high HIV burden, 12-18-2002.
• Dextrin sulfate safe and acceptable as a vaginal microbicide, 12-12-2002.
• Antagonism of gp120 might treat HIV-related cognitive impairment, 12-6-2002.
• HPV+ women with normal Pap at substantial risk of future abnormal Pap, 12-6-2002.
• Resistant HIV becomes more resistant, but less fit, if same therapy maintained, 11-15-2002.
• Ritonavir damage to endothelial cells may explain its adverse vascular effects, 10-25-2002.
• Disadvantage from prior nucleoside therapy persists for years during HAART, 10-17-2002.
• Oral candidiasis in HAART era generally caused by azole-susceptible Candida, 10-2-2002.
• Gleevec and other c-Kit inhibitors might treat Kaposi’s sarcoma, 8-22-2002.
• Polyprotein vaccine protects mice against cutaneous leishmaniasis, 8-15-2002.
• Antichlamydial effect of aspirin might explain its cardioprotective activity, 8-1-2002.
• Protease inhibitor use linked to changes in cardiac structure and function, 7-24-2002.
• Tenofovir DF active against resistant HIV in treatment-experienced patients, 6-11-2002.
• Fat redistribution not common in HIV-infected children receiving HAART, 6-6-2002.
• KS-associated herpesvirus infection common in HIV-negative gay men, 4-5-2002.
• Passive immunization via nasal mucosa protects SCID mice from pneumonia, 3-25-2002.
• Women might have better HAART outcomes than men, 3-13-2002.
• Reseeding of viral reservoirs may explain poor response to HAART interruption, 2-14-2002.
• Hepatotoxicity of PIs occurs mainly in HIV patients co-infected with hepatitis, 2-7-2002.
• Percutaneous embolotherapy controls life-threatening hemoptysis, 2-5-2002.
• Low-cost nevirapine regimen prevents vertical HIV transmission, 7-15-1999.
• 1918 influenza virus not avian; cause of virulence still unknown, 2-17-1999.
• Hemoglobin E trait associated with milder course of falciparum malaria, 1-6-1999.
• Women can contract humanpapilloma virus from sex with women, 12-21-1998.
• US colleges, universities urged to target TB screening to high-risk students, 12-18-1998.
• Rare HIV mutation can resist all nucleoside reverse transcriptase inhibitors, 11-17-1998.
• Pregnant women develop anti-adhesion antibodies to malaria, 10-29-1998.
• Access to medical care prolongs AIDS-free survival among drug users, 10-26-1998.
• AZT derivatives show promise as anti-HIV spermicides, 10-7-1998.
• Long-term famciclovir suppresses recurrences of genital herpes simplex virus, 9-9-1998.
• Nonoxynol-9 may potentiate rectal infection by herpes simplex virus, possibly HIV, 8-31-1998
• “Protein switching” by P. falciparum may affect severity of malaria, 7-23-1998.
• Vaccine based on collagen adhesin protects mice from Staph aureus, 6-15-1998.
• Antiviral effect of eosinophils results from secretory ribonucleases, 6-8-1998.